MeSH Review:
Glioblastoma
Vallera,
Jin,
Li,
Panoskaltsis-Mortari,
Hall,
Holland,
Dai,
Schaefer,
Fuller,
Celestino,
Sawaya,
Rajasekhar,
Holland,
Wiedmann,
Socci,
Hu,
Viale,
Brandes,
Tosoni,
Monfardini,
Cavallo,
Reni,
Basso,
Vastola,
Ferreri,
Scopece,
Panucci,
Ermani,
Stuart A. Grossman,
Myrna Rosenfeld,
Serena Desideri,
Steven Piantadosi,
Joy Fisher,
Louis B. Nabors,
Xiaobu Ye,
S. Horvath,
M.F. Laurance,
T.F. Cloughesy,
K.V. Lu,
M. Carlson,
S. Zhu,
P.G. Febbo,
D.H. Geschwind,
R.M. Felciano,
L.M. Liau,
S. Qi,
Z. Chen,
B. Zhang,
Y. Lee,
W. Zhao,
A.C. Scheck,
P.S. Mischel,
H. Wu,
H.I. Kornblum,
S.F. Nelson,
- Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. Reilly, K.M., Loisel, D.A., Bronson, R.T., McLaughlin, M.E., Jacks, T. Nat. Genet. (2000)
- Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Seoane, J., Le, H.V., Shen, L., Anderson, S.A., Massagué, J. Cell (2004)
- Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Kwon, C.H., Zhu, X., Zhang, J., Knoop, L.L., Tharp, R., Smeyne, R.J., Eberhart, C.G., Burger, P.C., Baker, S.J. Nat. Genet. (2001)
- Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor. Van Nostrand, W.E., Wagner, S.L., Suzuki, M., Choi, B.H., Farrow, J.S., Geddes, J.W., Cotman, C.W., Cunningham, D.D. Nature (1989)
- Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Holland, E.C., Celestino, J., Dai, C., Schaefer, L., Sawaya, R.E., Fuller, G.N. Nat. Genet. (2000)
- Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Bargmann, C.I., Hung, M.C., Weinberg, R.A. Cell (1986)
- Radiation plus metronidazole for glioblastoma. Urtasun, R.C., Band, P.R., Chapman, J.D., Feldstein, M.L. N. Engl. J. Med. (1977)
- Gene therapy of experimental brain tumors using neural progenitor cells. Benedetti, S., Pirola, B., Pollo, B., Magrassi, L., Bruzzone, M.G., Rigamonti, D., Galli, R., Selleri, S., Di Meco, F., De Fraja, C., Vescovi, A., Cattaneo, E., Finocchiaro, G. Nat. Med. (2000)
- Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Millauer, B., Shawver, L.K., Plate, K.H., Risau, W., Ullrich, A. Nature (1994)
- Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Van Meir, E.G., Polverini, P.J., Chazin, V.R., Su Huang, H.J., de Tribolet, N., Cavenee, W.K. Nat. Genet. (1994)
- Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Lee, J.O., Yang, H., Georgescu, M.M., Di Cristofano, A., Maehama, T., Shi, Y., Dixon, J.E., Pandolfi, P., Pavletich, N.P. Cell (1999)
- The neu oncogene encodes an epidermal growth factor receptor-related protein. Bargmann, C.I., Hung, M.C., Weinberg, R.A. Nature (1986)
- Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Trojan, J., Johnson, T.R., Rudin, S.D., Ilan, J., Tykocinski, M.L., Ilan, J. Science (1993)
- Quality and duration of survival in glioblastoma multiforme. Combined surgical, radiation, and lomustine therapy. Hochberg, F.H., Linggood, R., Wolfson, L., Baker, W.H., Kornblith, P. JAMA (1979)
- Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival. Eoli, M., Menghi, F., Bruzzone, M.G., De Simone, T., Valletta, L., Pollo, B., Bissola, L., Silvani, A., Bianchessi, D., D'Incerti, L., Filippini, G., Broggi, G., Boiardi, A., Finocchiaro, G. Clin. Cancer Res. (2007)
- Potential therapeutic effect of glycogen synthase kinase 3beta inhibition against human glioblastoma. Miyashita, K., Kawakami, K., Nakada, M., Mai, W., Shakoori, A., Fujisawa, H., Hayashi, Y., Hamada, J., Minamoto, T. Clin. Cancer Res. (2009)
- Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States. Grossman, S.A., Ye, X., Piantadosi, S., Desideri, S., Nabors, L.B., Rosenfeld, M., Fisher, J. Clin. Cancer Res. (2010)
- Bortezomib Primes Glioblastoma, Including Glioblastoma Stem Cells, for TRAIL by Increasing tBid Stability and Mitochondrial Apoptosis. Unterkircher, T., Cristofanon, S., Vellanki, S.H., Nonnenmacher, L., Karpel-Massler, G., Wirtz, C.R., Debatin, K.M., Fulda, S. Clin. Cancer Res. (2011)
- The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomas. Gini, B., Zanca, C., Guo, D., Matsutani, T., Masui, K., Ikegami, S., Yang, H., Nathanson, D., Villa, G.R., Shackelford, D., Zhu, S., Tanaka, K., Babic, I., Akhavan, D., Lin, K., Assuncao, A., Gu, Y., Bonetti, B., Mortensen, D.S., Xu, S., Raymon, H.K., Cavenee, W.K., Furnari, F.B., James, C.D., Kroemer, G., Heath, J.R., Hege, K., Chopra, R., Cloughesy, T.F., Mischel, P.S. Clin. Cancer Res. (2013)
- Direct inhibition of retinoblastoma phosphorylation by nimbolide causes cell-cycle arrest and suppresses glioblastoma growth. Karkare, S., Chhipa, R.R., Anderson, J., Liu, X., Henry, H., Gasilina, A., Nassar, N., Roychoudhury, J., Clark, J.P., Kumar, A., Pauletti, G.M., Ghosh, P.K., Dasgupta, B. Clin. Cancer Res. (2014)
- Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., Toyoshima, K. Nature (1986)
- Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells. Tenan, M., Fulci, G., Albertoni, M., Diserens, A.C., Hamou, M.F., El Atifi-Borel, M., Feige, J.J., Pepper, M.S., Van Meir, E.G. J. Exp. Med. (2000)
- PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. Smith, J.S., Tachibana, I., Passe, S.M., Huntley, B.K., Borell, T.J., Iturria, N., O'Fallon, J.R., Schaefer, P.L., Scheithauer, B.W., James, C.D., Buckner, J.C., Jenkins, R.B. J. Natl. Cancer Inst. (2001)
- Overexpression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas. Gerosa, M.A., Talarico, D., Fognani, C., Raimondi, E., Colombatti, M., Tridente, G., De Carli, L., Della Valle, G. J. Natl. Cancer Inst. (1989)
- Effect of recombinant fibroblast interferon and recombinant immune interferon on growth and the antigenic phenotype of multidrug-resistant human glioblastoma multiforme cells. Reddy, P.G., Graham, G.M., Datta, S., Guarini, L., Moulton, T.A., Jiang, H.P., Gottesman, M.M., Ferrone, S., Fisher, P.B. J. Natl. Cancer Inst. (1991)
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Shweiki, D., Itin, A., Soffer, D., Keshet, E. Nature (1992)
- PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Gao, T., Furnari, F., Newton, A.C. Mol. Cell (2005)
- Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. Rajasekhar, V.K., Viale, A., Socci, N.D., Wiedmann, M., Hu, X., Holland, E.C. Mol. Cell (2003)
- Targeting urokinase-type plasminogen activator receptor on human glioblastoma tumors with diphtheria toxin fusion protein DTAT. Vallera, D.A., Li, C., Jin, N., Panoskaltsis-Mortari, A., Hall, W.A. J. Natl. Cancer Inst. (2002)
- Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. Hermansson, M., Nistér, M., Betsholtz, C., Heldin, C.H., Westermark, B., Funa, K. Proc. Natl. Acad. Sci. U.S.A. (1988)
- A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Rubin, J.B., Kung, A.L., Klein, R.S., Chan, J.A., Sun, Y., Schmidt, K., Kieran, M.W., Luster, A.D., Segal, R.A. Proc. Natl. Acad. Sci. U.S.A. (2003)
- Expression and rearrangement of the ROS1 gene in human glioblastoma cells. Birchmeier, C., Sharma, S., Wigler, M. Proc. Natl. Acad. Sci. U.S.A. (1987)
- mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo. Kwon, C.H., Zhu, X., Zhang, J., Baker, S.J. Proc. Natl. Acad. Sci. U.S.A. (2003)
- Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Horvath, S., Zhang, B., Carlson, M., Lu, K.V., Zhu, S., Felciano, R.M., Laurance, M.F., Zhao, W., Qi, S., Chen, Z., Lee, Y., Scheck, A.C., Liau, L.M., Wu, H., Geschwind, D.H., Febbo, P.G., Kornblum, H.I., Cloughesy, T.F., Nelson, S.F., Mischel, P.S. Proc. Natl. Acad. Sci. U.S.A. (2006)
- Inhibition of glioblastoma growth in a highly invasive nude mouse model can be achieved by targeting epidermal growth factor receptor but not vascular endothelial growth factor receptor-2. Martens, T., Laabs, Y., Günther, H.S., Kemming, D., Zhu, Z., Witte, L., Hagel, C., Westphal, M., Lamszus, K. Clin. Cancer Res. (2008)
- IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Nobusawa, S., Watanabe, T., Kleihues, P., Ohgaki, H. Clin. Cancer Res. (2009)
- Microarray analysis verifies two distinct phenotypes of glioblastomas resistant to antiangiogenic therapy. Delay, M., Jahangiri, A., Carbonell, W.S., Hu, Y.L., Tsao, S., Tom, M.W., Paquette, J., Tokuyasu, T.A., Aghi, M.K. Clin. Cancer Res. (2012)
- Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Jacobs, A., Voges, J., Reszka, R., Lercher, M., Gossmann, A., Kracht, L., Kaestle, C., Wagner, R., Wienhard, K., Heiss, W.D. Lancet (2001)
- Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone. Kiaris, H., Schally, A.V. Proc. Natl. Acad. Sci. U.S.A. (1999)
- Synthesis and secretion of proteins resembling platelet-derived growth factor by human glioblastoma and fibrosarcoma cells in culture. Pantazis, P., Pelicci, P.G., Dalla-Favera, R., Antoniades, H.N. Proc. Natl. Acad. Sci. U.S.A. (1985)
- Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function. Krieg, M., Marti, H.H., Plate, K.H. Blood (1998)
- First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia. Brandes, A.A., Basso, U., Reni, M., Vastola, F., Tosoni, A., Cavallo, G., Scopece, L., Ferreri, A.J., Panucci, M.G., Monfardini, S., Ermani, M. J. Clin. Oncol. (2004)